Oxford Immunotec to go public, while Veracyte ups target
This article was originally published in Clinica
Another diagnostics company is looking to go public – this time, UK tuberculosis testing specialist Oxford Immunotec. The firm hopes to raise around $86m by floating on the Nasdaq Global Market under the ticker symbol OXFD. It did not disclose how many shares it plans to sell or at what price.